MedPath

Ischemic Preconditioning and Thiol-disulfide Balance

Not Applicable
Completed
Conditions
Tourniquets
Interventions
Other: Remote Ischemic Preconditioning
Other: sham group
Registration Number
NCT05082207
Lead Sponsor
Konya Meram State Hospital
Brief Summary

Various strategies have been proposed to prevent or mitigate the effects of ischemia-reperfusion injury following the use of tourniquets in orthopedic surgery cases. One of them is applying "remote ischemic preconditioning." This randomized controlled trial is planned to evaluate the effectiveness of remote ischemic preconditioning in preventing tourniquet-induced ischemia-reperfusion injury in total knee arthroscopy with dynamic thiol-disulfide homeostasis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • ASA I-III patients who will undergo total knee arthroplasty surgery under elective conditions
Exclusion Criteria
  • emergency operation,
  • Underlying neurological disorder,
  • Underlying peripheral vascular disease,
  • other types of concurrent surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Remote Ischaemic preconditioning (RIPC)Remote Ischemic PreconditioningThe group underwent Remote Ischemic Preconditioning.
Sham Groupsham groupSham control group without remote ischemic preconditioning
Primary Outcome Measures
NameTimeMethod
thiol/disulfide homeostasis24th hour after surgery

Thiol/disulphide homeostasis will be determined at preoperatively and just before the tourniquet opened and at the 1st, 6th and 24th hours after the tourniquet is opened.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Betul Kozanhan

🇹🇷

Konya, Turkey

© Copyright 2025. All Rights Reserved by MedPath